AustVASociety

AVAS was established for vascular access clinicians to network & develop the specialty through research, practice & education. Posts by the AVAS Executive Team.

[AustVASociety @AVASociety]

https://t.co/Qhr7PBVT2a

[AustVASociety @AVASociety]

AVAS is hosting an education event in Sydney. Perfecting the PICC.

[AustVASociety @AVASociety]

VeinTech are an Australian-based medical device company looking to better understand one of the key procedures you perform as a qualified healthcare provider: starting an IV. 
Please click the link below to start the survey:
https://t.co/JysYNtt0Dl

[AustVASociety @AVASociety]

We are incredibly proud of AVAS members @a_ullman and @Claire_AVATAR on this outstanding achievement. This research will contribute to reducing CVC complications in children with cancer. Well done Amanda and Claire!

[Amanda Ullman @amanda_ullman]

I am honoured & excited by the investment from @nhmrc as an IG to reduce CVC complications for kids w cancer & build capacity for the future.

I am also excited that we get to DO the research, rather than PROPOSE the research, for the next 5 years.

@UQHealth @childhealthqld

[Rebecca Sharp @reb_sharp]

Do you want to do a fully funded PhD to improve one of the fastest growing sectors in health?
👇

Join us @RBRCUniSA for a project to develop better support mechanisms for caregivers of people having intravenous antibiotics at home.
Further details here https://t.co/vqeM6ciGoH

[AustVASociety @AVASociety]

Journal Alert! AVAS has partnered with the Canadian Vascular Access Association. AVAS Members can now disseminate their work and access a broader range of leading-edge theories, developments, research, and practices: https://t.co/b3J5eoB4zz

[AustVASociety @AVASociety]

SA AVAS would like to thank @FloMedical for supporting our event this evening.
Great turnout from clinicians interested in Vascular Access.

[AustVASociety @AVASociety]

Kim’s research looking at adverse events of Umbilical Vein Catheters (UVC) and Umbilical Artery Catheters (UAC). Systematic review and meta analysis - adverse events UVC’s 13% UAC’s 9%

[AustVASociety @AVASociety]

Kim reports CDC recommends Umbilical Vein Catheters can be used for up to 14 days.

[AustVASociety @AVASociety]

Kim presenting last session tonight

[AustVASociety @AVASociety]

WCH FAARI service reducing multiple attempts for IV access. Provide advice service as well.

[AustVASociety @AVASociety]

Next speakers for the night Jacinta and Catherine

[AustVASociety @AVASociety]

Empowering patients to understand their PICC lines is important. Can assist with management at home and feeling comfortable living with.

[AustVASociety @AVASociety]

@reb_sharp looking at needs framework for living with PICC. What are patient needs?

[AustVASociety @AVASociety]

PICC: catheter to vein ration (CVR) can increase thrombus risk. @reb_sharp suggests <45% CVR reduces risk. CVR >45% doubles risk.

[AustVASociety @AVASociety]

First speaker for the night. Rebecca Sharp, president AVAS.

[AustVASociety @AVASociety]

Looking forward to tonight’s presentation.